Authors:
Kaufmann, GR
Suzuki, K
Cunningham, P
Mukaide, M
Kondo, M
Imai, M
Zaunders, J
Cooper, DA
Citation: Gr. Kaufmann et al., Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs, AIDS RES H, 17(6), 2001, pp. 487-497
Authors:
Suzuki, K
Kaufmann, GR
Mukaide, M
Cunningham, P
Harris, C
Leas, L
Kondo, M
Imai, M
Pett, SL
Finlayson, R
Zaunders, J
Kelleher, A
Cooper, DA
Citation: K. Suzuki et al., Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine, AIDS RES H, 17(13), 2001, pp. 1293-1296
Authors:
Tanaka, Y
Orito, E
Ohno, T
Nakano, T
Hayashi, K
Kato, T
Mukaide, M
Iida, S
Mizokami, M
Citation: Y. Tanaka et al., Identification of a novel 23 kDa protein encoded by putative open reading frame 2 of TT virus (TTV) genotype 1 different from the other genotypes, ARCH VIROL, 145(7), 2000, pp. 1385-1398
Authors:
Ohshima, S
Komatsu, M
Nakane, K
Meng, XW
Goto, T
Fujii, T
Yoneyama, K
Wada, Y
Tobori, F
Mukaide, M
Masamune, O
Watanabe, S
Citation: S. Ohshima et al., Iatrogenic GB virus C/hepatitis G virus infection in an area endemic for hepatitis C virus, J HOSP INF, 44(3), 2000, pp. 179-185
Authors:
Okuda, M
Hino, K
Korenaga, M
Yamaguchi, Y
Katoh, Y
Mukaide, M
Kaneda, Y
Minaminozono, T
Okita, K
Citation: M. Okuda et al., GB virus C/hepatitis G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients, J CLIN GAST, 30(4), 2000, pp. 425-428
Authors:
Tokita, H
Kaufmann, GR
Matsubayashi, M
Okuda, I
Tanaka, T
Harda, H
Mukaide, M
Suzuki, K
Cooper, DA
Citation: H. Tokita et al., Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassay, J CLIN MICR, 38(9), 2000, pp. 3450-3452
Authors:
Kato, H
Mizokami, M
Orito, E
Ohno, T
Hayashi, K
Nakano, T
Kato, T
Tanaka, Y
Sugauchi, F
Mukaide, M
Ueda, R
Citation: H. Kato et al., Lack of association between TTV viral load and aminotransferase levels in patients with hepatitis C or non-B-C, SC J IN DIS, 32(3), 2000, pp. 259-262
Authors:
Kato, T
Mizokami, M
Orito, E
Nakano, T
Tanaka, Y
Ueda, R
Hirashima, N
Iijima, Y
Kato, T
Sugauchi, F
Mukaide, M
Shimamatsu, K
Kage, M
Kojiro, M
Citation: T. Kato et al., High prevalence of TT virus infection in Japanese patients with liver diseases and in blood donors, J HEPATOL, 31(2), 1999, pp. 221-227
Authors:
Kato, T
Mizokami, M
Orito, E
Ohba, K
Nakano, T
Kondo, Y
Tanaka, Y
Ueda, R
Mukaide, M
Yasuda, K
Iino, S
Citation: T. Kato et al., Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy, J MED VIROL, 57(4), 1999, pp. 376-382
Authors:
Mizokami, M
Nakano, T
Orito, E
Tanaka, Y
Sakugawa, H
Mukaide, M
Robertson, BH
Citation: M. Mizokami et al., Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns, FEBS LETTER, 450(1-2), 1999, pp. 66-71